119 related articles for article (PubMed ID: 2437001)
1. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
[TBL] [Abstract][Full Text] [Related]
2. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.
Shouval D; Eilat D; Carlson RI; Adler R; Livni N; Wands JR
Hepatology; 1985; 5(3):347-56. PubMed ID: 2987098
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5.
Dunk AA; Brown D; Weidmann K; Thomas HC
J Hepatol; 1987 Feb; 4(1):52-61. PubMed ID: 3033060
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
Kiyosawa K; Daemer RJ; He LF; Bonino F; Prozesky OW; Purcell RH
Hepatology; 1985; 5(4):548-55. PubMed ID: 2991105
[TBL] [Abstract][Full Text] [Related]
5. Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.
Carlson RI; Ben-Porath E; Shouval D; Strauss W; Isselbacher KJ; Wands JR
J Clin Invest; 1985 Jul; 76(1):40-51. PubMed ID: 2991342
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies directed to a disulfated glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), associated with human hepatocellular carcinoma.
Hiraiwa N; Iida N; Ishizuka I; Itai S; Shigeta K; Kannagi R; Fukuda Y; Imura H
Cancer Res; 1988 Dec; 48(23):6769-74. PubMed ID: 2846160
[TBL] [Abstract][Full Text] [Related]
7. Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
Hosokawa S; Muramatsu M; Nagaike K
Cancer Res; 1989 Jan; 49(2):361-6. PubMed ID: 2463075
[TBL] [Abstract][Full Text] [Related]
8. Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line.
Wen YM; Copeland JA; Mann GF; Howard CR; Zuckerman AJ
Arch Virol; 1981; 68(3-4):157-63. PubMed ID: 6268017
[TBL] [Abstract][Full Text] [Related]
9. Identification of human hepatoma-defined cell surface molecules.
Moriarity DM; Fox N; Aden DP; Hoyer JR; Knowles BB
Hybridoma; 1983; 2(1):39-47. PubMed ID: 6205970
[TBL] [Abstract][Full Text] [Related]
10. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
Shao RP
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):259-61. PubMed ID: 3019621
[TBL] [Abstract][Full Text] [Related]
11. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients.
Chen YM; Hu CP; Chen PH; Chu MH; Tsai YT; Lee SD; Chang CM
Hepatology; 1988; 8(3):547-52. PubMed ID: 2836290
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
13. Serological analysis and biochemical characterization of monoclonal antibodies defining antigens of human hepatocellular carcinoma.
Chang KJ; Finstad CL; Chen PD; Knowles DM; Wang CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Feb; 22(1):1-20. PubMed ID: 2551603
[TBL] [Abstract][Full Text] [Related]
14. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
15. Production of monoclonal antibodies against human hepatocellular carcinoma by immunisation with a cell membrane preparation.
Tan LS
Ann Acad Med Singap; 1990 Mar; 19(2):147-51. PubMed ID: 1693262
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells.
Hu CP; Han SH; Lui WY; Hsu HC; Lin YM; Lin PH; Chen LR; Hsieh HG; Kuo PT; P'eng FK
Hepatology; 1986; 6(6):1396-402. PubMed ID: 3025071
[TBL] [Abstract][Full Text] [Related]
17. [Production and characterization of anti-human hepatocellular carcinoma monoclonal antibodies].
Peng H; Cao Z; Zhou S; Wang Z; Lei B; Zhao L
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):259-62. PubMed ID: 1965504
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against human esophageal carcinoma cell lines.
Hsieh HG; Hu CP; Han SH; Chen LR; Chien KY; Chou CK; Ting LP; Su TS; Huang MH; Hsu WH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):179-89. PubMed ID: 2827967
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of newly established monoclonal antibodies against hepatocellular carcinomas.
Ohzu K; Hasegawa K; Yamauchi K; Obata H
J Gastroenterol Hepatol; 1990; 5(6):601-7. PubMed ID: 1966596
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization.
Trejdosiewicz LK; Southgate J; Donald JA; Masters JR; Hepburn PJ; Hodges GM
J Urol; 1985 Mar; 133(3):533-8. PubMed ID: 2579255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
